These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 25835116

  • 1. The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients.
    Mostafa T, Badra G, Abdallah M.
    Turk J Gastroenterol; 2015 Mar; 26(2):163-9. PubMed ID: 25835116
    [Abstract] [Full Text] [Related]

  • 2. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.
    Elfert A, Abo Ali L, Soliman S, Ibrahim S, Abd-Elsalam S.
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1450-1454. PubMed ID: 27512927
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.
    Assem M, Elsabaawy M, Abdelrashed M, Elemam S, Khodeer S, Hamed W, Abdelaziz A, El-Azab G.
    Hepatol Int; 2016 Mar; 10(2):377-85. PubMed ID: 26660707
    [Abstract] [Full Text] [Related]

  • 4. Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites.
    Lutz P, Parcina M, Bekeredjian-Ding I, Nischalke HD, Nattermann J, Sauerbruch T, Hoerauf A, Strassburg CP, Spengler U.
    PLoS One; 2014 Mar; 9(4):e93909. PubMed ID: 24714550
    [Abstract] [Full Text] [Related]

  • 5. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial.
    Pande C, Kumar A, Sarin SK.
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):831-9. PubMed ID: 22522141
    [Abstract] [Full Text] [Related]

  • 6. The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Hanouneh MA, Hanouneh IA, Hashash JG, Law R, Esfeh JM, Lopez R, Hazratjee N, Smith T, Zein NN.
    J Clin Gastroenterol; 2012 Sep; 46(8):709-15. PubMed ID: 22878533
    [Abstract] [Full Text] [Related]

  • 7. Selective intestinal decontamination with norfloxacin enhances a regulatory T cell-mediated inflammatory control mechanism in cirrhosis.
    Juanola O, Gómez-Hurtado I, Zapater P, Moratalla A, Caparrós E, Piñero P, González-Navajas JM, Giménez P, Such J, Francés R.
    Liver Int; 2016 Dec; 36(12):1811-1820. PubMed ID: 27214392
    [Abstract] [Full Text] [Related]

  • 8. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis.
    Francés R, Zapater P, González-Navajas JM, Muñoz C, Caño R, Moreu R, Pascual S, Bellot P, Pérez-Mateo M, Such J.
    Hepatology; 2008 Mar; 47(3):978-85. PubMed ID: 18306221
    [Abstract] [Full Text] [Related]

  • 9. The role of rifaximine in the prevention of the spontaneous bacterial peritonitis.
    Dănulescu RM, Ciobică A, Stanciu C, Trifan A.
    Rev Med Chir Soc Med Nat Iasi; 2013 Mar; 117(2):315-20. PubMed ID: 24340510
    [Abstract] [Full Text] [Related]

  • 10. Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites.
    Corradi F, Brusasco C, Fernández J, Vila J, Ramirez MJ, Seva-Pereira T, Fernández-Varo G, Mosbah IB, Acevedo J, Silva A, Rocco PR, Pelosi P, Gines P, Navasa M.
    Dig Liver Dis; 2012 Mar; 44(3):239-44. PubMed ID: 22119621
    [Abstract] [Full Text] [Related]

  • 11. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis.
    Chen TA, Tsao YC, Chen A, Lo GH, Lin CK, Yu HC, Cheng LC, Hsu PI, Tsai WL.
    Scand J Gastroenterol; 2009 Mar; 44(5):619-25. PubMed ID: 19191184
    [Abstract] [Full Text] [Related]

  • 12. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
    Novella M, Solà R, Soriano G, Andreu M, Gana J, Ortiz J, Coll S, Sàbat M, Vila MC, Guarner C, Vilardell F.
    Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
    [Abstract] [Full Text] [Related]

  • 13. Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study.
    Lv XY, Ding HG, Zheng JF, Fan CL, Li L.
    World J Gastroenterol; 2020 Jan 14; 26(2):199-218. PubMed ID: 31988585
    [Abstract] [Full Text] [Related]

  • 14. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
    Sandhu BS, Gupta R, Sharma J, Singh J, Murthy NS, Sarin SK.
    J Gastroenterol Hepatol; 2005 Apr 14; 20(4):599-605. PubMed ID: 15836710
    [Abstract] [Full Text] [Related]

  • 15. Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial.
    Yim HJ, Suh SJ, Jung YK, Yim SY, Seo YS, Lee YR, Park SY, Jang JY, Kim YS, Kim HS, Kim BI, Um SH.
    Am J Gastroenterol; 2018 Aug 14; 113(8):1167-1176. PubMed ID: 29946179
    [Abstract] [Full Text] [Related]

  • 16. Antibiotics for prophylaxis of spontaneous bacterial peritonitis: systematic review & Bayesian network meta-analysis.
    Soni H, Kumar-M P, Sharma V, Bellam BL, Mishra S, Mahendru D, Mandavdhare HS, Medhi B, Dutta U, Singh V.
    Hepatol Int; 2020 May 14; 14(3):399-413. PubMed ID: 32266675
    [Abstract] [Full Text] [Related]

  • 17. Norfloxacin versus alternative antibiotics for prophylaxis of spontaneous bacteria peritonitis in cirrhosis: a systematic review and meta-analysis.
    Song S, Yang Y, Geng C, Tang Z, Wang C, Li X.
    BMC Infect Dis; 2023 Aug 28; 23(1):557. PubMed ID: 37641014
    [Abstract] [Full Text] [Related]

  • 18. Patients with spontaneous bacterial peritonitis, and malignant and cirrhotic ascites.
    Yildirim B, Sari R, Isci N.
    J Natl Med Assoc; 2005 Feb 28; 97(2):276-80. PubMed ID: 15712792
    [Abstract] [Full Text] [Related]

  • 19. Safety and Efficacy of Rifaximin in Prophylaxis of Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-analysis.
    Menshawy A, Mattar O, Barssoum K, AboEl-Naga AM, Salim HM, Mohamed AMF, Elgebaly A, Abd-Elsalam S.
    Curr Drug Targets; 2019 Feb 28; 20(4):380-387. PubMed ID: 30246636
    [Abstract] [Full Text] [Related]

  • 20. Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis.
    Goel A, Rahim U, Nguyen LH, Stave C, Nguyen MH.
    Aliment Pharmacol Ther; 2017 Dec 28; 46(11-12):1029-1036. PubMed ID: 28994123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.